Professor Mark Rowland MSc PhD
- Mark Rowland's Contacts
- Keppel Street
- WC1E 7HT
- T: 020 7299 4719
Mark Rowland's Background
Mark Rowland is Head of Department of Disease Control and Deputy Director of the Malaria Centre. He is a medical entomologist working primarily on the development and evaluation of new methods of malaria vector control.
Mark is Coordinator of PAMVERC, the Pan-African Vector Research Consortium, which is an alliance of research institutions, laboratories and field sites in East and West Africa (Tanzania [Muheza, Moshi, Muleba], Benin and Ivory Coast) for trialing of new vector control tools to improve malaria transmission control and overcome insecticide resistance.
He has special interest in vector borne disease control in countries affected by crisis and conflict. From 1991 to 1998 he managed the malaria and leishmaniasis control programme of HealthNet-TPO, Medecins sans Frontières and UNHCR for Afghanistan and the Afghan refugee populations living in Pakistan. Since returning to LSHTM in 1999 Mark has maintained and built research links with health NGOs working in Afghanistan, Pakistan and Africa.
During the last decade Mark has worked with DFID funded research consortia on integrated malaria control in emergencies (epidemiology, medical entomology and malaria chemotherapy) and with the Innovative Vector Control Consortium and private sector manufacturers on vector control product development. He has worked with the WHO Pesticide Evaluation Scheme for over 15 years on the evaluation of mosquito control products, and is a member of the WHO Technical Expert Group on Malaria Vector Control.
Mark Rowland's Affiliation
Mark Rowland's Teaching
Mark organises the study module on Vector Biology and Vector Parasite Interactions. He tutors on various MSc courses (Medical Entomology for Disease Control, Medical Parasitology, Control of Infectious Diseases), teaches on various modules (Core Entomology and Parasitology, Integrated Vector Management, and Malaria Epidemiology and Control) and field courses. He supervises PhD students in Tanzania, Benin, Afghanistan and UK.
Mark Rowland's Research
Research projects in 4 areas:
1. Malaria transmission control. Community randomised trials in Tanzania to investigate:
· The impact of combined indoor residual spraying and universal coverage of long lasting nets on malaria transmission control in Tanzania (supported by USAID and President Malaria Initiative).
· Whether pyrethroid treated blankets/sheets can provide community protection against malaria in situations analogous to humanitarian crisis.
2. Development of new vector control tools:
Development and evaluation of products that provide improved control and overcome pyrethroid resistance. These include long-lasting indoor residual spray formulations and combination long-lasting nets. Projects are supported through the Innovative Vector Control Consortium (IVCC), a Gates funded product-development-partnership with agrochemical and textile industry, implemented through PAMVERC in Tanzania and Benin.
Trials of combination products to improve vector control and manage resistance in Africa (AvecNet).
3. Evaluation of new vector control tools:
· Evaluation of new vector control products (LLINs and combination nets) on behalf of the WHO Pesticide Evaluation Scheme (WHOPES). Phase II trials of efficacy and wash resistance in experimental huts, Phase III trials of LLIN effectiveness and durability are evaluated in household randomised trials.
· Comparative studies with prototype or commercial products in laboratory, semi-field or village trials sponsored by manufacturing industry.
4. Targeting of Rapid Diagnostic Tests (RDT) and Artemesinin Combination Therapy (ACT) for improved management of falciparum and vivax malaria in Afghanistan. A multidisciplinary project funded by the ACT Consortium implemented through the several international and local health care NGOs operating in northern and eastern Afghanistan.
- Clinical trials
- Drug resistance
- Implementation research
- Public health
- Randomised controlled trials
- Vector control
- Operational research
- Vector biology
Disease and Health Conditions
- Infectious disease
- Neglected Tropical Diseases (NTDs)
- South Asia
- Sub-Saharan Africa (developing only)
- Burkina Faso
- Cote d'Ivoire
- Health In Fragile Countries
Control of pyrethroid and DDT-resistant Anopheles gambiae by application of indoor residual spraying or mosquito nets treated with a long-lasting organophosphate insecticide, chlorpyrifos-methyl.
N'guessan, R.; Boko, P.; Odjo, A.; Chabi, J.; Akogbeto, M.; Rowland, M.;
Malar J, 2010; 9(1):44
The Impact of Phenotypic and Genotypic G6PD Deficiency on Risk of Plasmodium vivax Infection: A Case-Control Study amongst Afghan Refugees in Pakistan.
Leslie, T.; Briceño, M.; Mayan, I.; Mohammed, N.; Klinkenberg, E.; Sibley, C.H.; Whitty, C.J.; Rowland, M.;
PLoS Med, 2010; 7(5):e1000283
A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.
Leslie, T.; Mayan, I.; Mohammed, N.; Erasmus, P.; Kolaczinski, J.; Whitty, C.J.; Rowland, M.;
PLoS ONE, 2008; 3(8):e2861
Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area, Benin
N'Guessan, R.; Corbel, V.; Akogbéto, M.; Rowland, M.;
Emerging Infectious Diseases, 2007; 13(2):199-206
Hill, J.; Lines, J.; Rowland, M.;
Adv Parasitol, 2006; 61:77-128
Malaria control in Afghanistan: progress and challenges.
Kolaczinski, J.; Graham, K.; Fahim, A.; Brooker, S.; Rowland, M.;
Lancet, 2005; 365(9469):1506-12
DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan
Rowland, M.; Downey, G.; Rab, A.; Freeman, T.; Mohammad, N.; Rehman, H.; Durrani, N.; Reyburn, H.; Curtis, C.; Lines, J.; Fayaz, M.
Tropical Medicine & International Health, 2004; 9(3):335-42
Control of malaria in Pakistan by applying deltamethrin insecticide to cattle: a community-randomised trial
Rowland, M.; Durrani, N.; Kenward, M.; Mohammed, N.; Urahman, H.; Hewitt, S.
Lancet, 2001; 357(9271):1837-1841
- → View all Professor Mark Rowland's publications